Geneva, June 20 -- International Clinical Trials Registry received information related to the study (NCT07020559) titled 'Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized Controlled Trial' on June 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Peking University Third Hospital
Condition:
Diabetic Wounds
Platelet Rich Plasma
Allogeneic Blood Transfusions
Renal Dysfunction
Intervention:
Drug: allogeneic platelet plasma
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 2025
Target Sample Size: 56
Countries of Recruitment:
Chi...